
Red Cat Holdings (RCAT) trades at $13.63 and Stock Options Channel highlights two options strategies: selling a $7.00 put (bid $0.03) would obligate purchase at an effective $6.97 cost basis — ~49% below current price — with a 92% probability of expiring worthless and a 0.43% yield (3.40% annualized). Alternatively, selling a $19.00 covered call (bid $0.11) against shares bought at $13.63 would cap upside but deliver a 40.21% total return to March 27 if called, with a 66% probability of expiring worthless and a 0.81% yield boost (6.41% annualized); implied vols are very high (puts 152%, calls 156%) versus a 12-month realized volatility of 115%.
Market structure: Option sellers and cash-rich retail/institutional income providers benefit from RCAT's elevated implied vol (152% IV vs 115% realized) because premium is rich relative to historical moves; market makers collecting theta are winners while pure momentum/long-only traders in small-cap defense/tech could be hurt by sudden hedging flows. The $7 put (bid $0.03) and $19 call (bid $0.11) imply asymmetric positioning — deep OTM downside protection demand is low (92% modeled expire worthless) while OTM upside remains plausible (34% chance to be ITM), suggesting a short-term skewed risk appetite rather than structural supply shock. Risk assessment: Tail risks include an idiosyncratic negative corporate surprise (contract loss, restatement or dilutive raise) that compresses equity >50% (to <$7) before Mar 27, or a liquidity event that widens spreads and prevents option exit. Immediate window (days–weeks) is dominated by decay into Mar 27 expiry; short-term (1–3 months) risk is IV reversion that can punish buyers of volatility; long-term (>6 months) depends on fundamentals (cash runway, backlogs) which are not covered here and could force equity dilution. Trade implications: If you want exposure, prefer a cash-secured put sell-to-open RCAT $7 Mar27 for a target entry at $6.97 (allocate no more than 1–3% of portfolio, max notional exposure equal to available cash) because reward (0.43% on cash, 3.4% annualized) is small but acceptance of assignment is clear. Alternative: buy RCAT at market and sell the $19 Mar27 covered call to create a capped 40.2% gross return if assigned; size as a tactical 1–2% position and close if stock moves >+15% or -20% intraday pre-expiry. For volatility sellers prefer shorter-dated (<=30 days) weekly contracts to harvest theta and avoid earnings gaps. Contrarian angles: Consensus favors selling these tiny premiums for yield, but execution risk (wide spreads, low contract liquidity) and gamma pinch near expiry can invert expected gains; selling puts at $7 only makes sense if you truly want to own RCAT at <$7 and ignore potential dilution. Historical parallels: small-cap, high-IV names that printed rich premiums often faced dilution or event risk within 3–6 months, so avoid layering beyond one contract cycle; set hard stop-loss: close option or hedge if IV spikes >200% or underlying gaps >25% intraday.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
neutral
Sentiment Score
0.10
Ticker Sentiment